Allison Wang

Allison Wang has been working in the field of portfolio and project management since 2006. Allison began their career at Bayer HealthCare as a Study Manager in 2006. In 2011, they moved to Novartis and became a Clinical Trial Head. In 2012, they joined Boehringer Ingelheim as an Associate Director and Trial Clinical Lead. In 2014, they were promoted to Associate Director and Project Management Lead at AstraZeneca. In 2021, they were appointed as the Head of Portfolio & Project Management, Vice President at D3 Bio.

Allison Wang has an educational background that spans two decades. Allison obtained their Bachelor's degree from China Pharmaceutical University between 1997 and 2001. Allison then went on to pursue an Executive MBA from CEIBS, which they are expected to complete in 2022.